PTX3 and endothelial dysfunction: Some biomarkers related with TGV activation, such as CGRP [35,36] or endothelial dysfunction, such as pentraxin-3 (PTX3) [37,38], have recently been described as predictors of good response to OnabotA in CM (measured in peripheral blood during interictal periods).